CN103619323B - 作为气溶胶团的伊洛前列素的给药 - Google Patents

作为气溶胶团的伊洛前列素的给药 Download PDF

Info

Publication number
CN103619323B
CN103619323B CN201280020036.5A CN201280020036A CN103619323B CN 103619323 B CN103619323 B CN 103619323B CN 201280020036 A CN201280020036 A CN 201280020036A CN 103619323 B CN103619323 B CN 103619323B
Authority
CN
China
Prior art keywords
composition
inhalation
aerosol
iloprost
inhaler
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201280020036.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN103619323A (zh
Inventor
T.格斯勒
T.施梅尔
W.泽格尔
R.福斯温克尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectura GmbH
Original Assignee
Activaero GmbH
Vectura GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Activaero GmbH, Vectura GmbH filed Critical Activaero GmbH
Priority to CN201610437339.7A priority Critical patent/CN106420676B/zh
Publication of CN103619323A publication Critical patent/CN103619323A/zh
Application granted granted Critical
Publication of CN103619323B publication Critical patent/CN103619323B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5578—Eicosanoids, e.g. leukotrienes or prostaglandins having a pentalene ring system, e.g. carbacyclin, iloprost
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/005—Sprayers or atomisers specially adapted for therapeutic purposes using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/06—Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0085—Inhalators using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0015—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
    • A61M2016/0018—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
    • A61M2016/0024—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with an on-off output signal, e.g. from a switch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201280020036.5A 2011-04-26 2012-04-26 作为气溶胶团的伊洛前列素的给药 Active CN103619323B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610437339.7A CN106420676B (zh) 2011-04-26 2012-04-26 作为气溶胶团的伊洛前列素的给药

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11163659 2011-04-26
EP11163659.3 2011-04-26
PCT/EP2012/057615 WO2012146642A1 (en) 2011-04-26 2012-04-26 Administration of iloprost as aerosol bolus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201610437339.7A Division CN106420676B (zh) 2011-04-26 2012-04-26 作为气溶胶团的伊洛前列素的给药

Publications (2)

Publication Number Publication Date
CN103619323A CN103619323A (zh) 2014-03-05
CN103619323B true CN103619323B (zh) 2016-08-17

Family

ID=44534909

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201280020036.5A Active CN103619323B (zh) 2011-04-26 2012-04-26 作为气溶胶团的伊洛前列素的给药
CN201610437339.7A Active CN106420676B (zh) 2011-04-26 2012-04-26 作为气溶胶团的伊洛前列素的给药

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201610437339.7A Active CN106420676B (zh) 2011-04-26 2012-04-26 作为气溶胶团的伊洛前列素的给药

Country Status (19)

Country Link
US (2) US20140155486A1 (enExample)
EP (2) EP2701683B1 (enExample)
JP (1) JP6066350B2 (enExample)
KR (1) KR101718372B1 (enExample)
CN (2) CN103619323B (enExample)
AU (1) AU2012247562B2 (enExample)
CA (1) CA2834063C (enExample)
CL (1) CL2013003057A1 (enExample)
CO (1) CO6821944A2 (enExample)
ES (1) ES2625282T3 (enExample)
IL (1) IL228182B (enExample)
NZ (1) NZ616048A (enExample)
PH (1) PH12013502152B1 (enExample)
PL (1) PL2701683T3 (enExample)
PT (1) PT2701683T (enExample)
RU (1) RU2605849C2 (enExample)
TW (1) TWI602568B (enExample)
WO (1) WO2012146642A1 (enExample)
ZA (1) ZA201307908B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2974809T3 (es) * 2012-10-31 2024-07-01 Vectura Gmbh Administración de iloprost en aerosol
US20160303040A1 (en) * 2013-11-19 2016-10-20 Rigshospitalet Injectable pharmaceutical compositions comprising prostacyclin
EP3082428A4 (en) 2013-12-09 2017-08-02 Respira Therapeutics, Inc. Pde5 inhibitor powder formulations and methods relating thereto
WO2017201349A1 (en) 2016-05-18 2017-11-23 Modernatx, Inc. Polynucleotides encoding citrin for the treatment of citrullinemia type 2
US20200360276A1 (en) 2019-05-16 2020-11-19 Aerovate Therapeutics, Inc. Inhalable imatinib metabolite formulations, manufacture, and uses thereof
US20250000873A1 (en) 2021-09-10 2025-01-02 Justus-Liebig-Universitaet Giessen Inhaled iloprost for rescue treatment and treatment as needed in pulmonary hypertension
CN113952320B (zh) * 2021-09-18 2022-03-18 健康元药业集团股份有限公司 一种包含妥布霉素吸入溶液的药物组件及其用途
CN113712526B (zh) * 2021-09-30 2022-12-30 四川大学 一种脉搏波提取方法、装置、电子设备及存储介质
CN114652704A (zh) * 2022-04-29 2022-06-24 兆科药业（广州）有限公司 一种曲前列尼尔软雾吸入剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6972869B2 (en) 2000-12-18 2005-12-06 Xerox Corporation Mapping color to colorant amounts when colorants have similar hue
WO2006014930A2 (en) 2004-07-26 2006-02-09 Cotherix, Inc. Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition
KR101390579B1 (ko) * 2006-05-15 2014-05-19 유나이티드 세러퓨틱스 코오포레이션 정량 흡입기를 사용한 트레프로스티닐 투여
PT2285439E (pt) 2008-04-04 2014-03-25 Nektar Therapeutics Dispositivo de aerossolização
US8668901B2 (en) * 2009-02-04 2014-03-11 Activaero Gmbh Research & Development Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
《Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension》;T.Gessler;《Eur Respir J》;20111231(第17期);第16页右栏第1段，第17页表1 *

Also Published As

Publication number Publication date
NZ616048A (en) 2015-07-31
US10821116B2 (en) 2020-11-03
AU2012247562B2 (en) 2015-12-17
PH12013502152A1 (en) 2014-01-13
ZA201307908B (en) 2014-07-30
US20140155486A1 (en) 2014-06-05
TW201249442A (en) 2012-12-16
CL2013003057A1 (es) 2014-08-01
PT2701683T (pt) 2017-05-03
WO2012146642A1 (en) 2012-11-01
KR101718372B1 (ko) 2017-03-21
TWI602568B (zh) 2017-10-21
CO6821944A2 (es) 2013-12-31
CN106420676A (zh) 2017-02-22
RU2605849C2 (ru) 2016-12-27
HK1190627A1 (zh) 2014-07-11
CN103619323A (zh) 2014-03-05
IL228182B (en) 2018-07-31
EP2965748A1 (en) 2016-01-13
PH12013502152B1 (en) 2018-12-14
EP2701683B1 (en) 2017-03-08
CA2834063A1 (en) 2012-11-01
CA2834063C (en) 2016-01-05
US20170014424A1 (en) 2017-01-19
AU2012247562A1 (en) 2013-09-26
KR20140012114A (ko) 2014-01-29
JP2014513091A (ja) 2014-05-29
ES2625282T3 (es) 2017-07-19
JP6066350B2 (ja) 2017-01-25
CN106420676B (zh) 2020-04-28
PL2701683T3 (pl) 2017-08-31
RU2013151018A (ru) 2015-06-27
EP2701683A1 (en) 2014-03-05

Similar Documents

Publication Publication Date Title
CN103619323B (zh) 作为气溶胶团的伊洛前列素的给药
US11357782B2 (en) Treprostinil administration by inhalation
JP5863641B2 (ja) 濃縮肥満細胞安定化用薬学的調合物
JP2017505348A (ja) 肺疾患治療のための肥満細胞安定剤
JP2023542629A (ja) 改良されたエアロゾルパラメータのための噴霧器デバイスの最適化及びその使用
CN104853744B (zh) 气溶胶化伊洛前列素的给药
JP7475065B2 (ja) 薬剤、肺胞の洗浄用の薬液、及び、ネブライザー
HK1190627B (en) Administration of iloprost as aerosol bolus
CN118201620A (zh) 吸入的伊洛前列素用于肺动脉高压的按需治疗
JP2025515512A (ja) トレプロスチニルソフトミスト吸入剤
Singhal et al. Aerosol Drug Delivery

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1190627

Country of ref document: HK

C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: German Pavilion

Applicant after: Wei Keduorui Co., Ltd

Address before: German Pavilion

Applicant before: Activaero GmbH

CB02 Change of applicant information

Address after: German High Court

Applicant after: Wei Keduorui Co., Ltd

Address before: German Pavilion

Applicant before: Wei Keduorui Co., Ltd

COR Change of bibliographic data
C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1190627

Country of ref document: HK